Related Experiment Video

Updated: Jun 27, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.6K

NALIRIFOX for metastatic pancreatic adenocarcinoma: hope or hype?

Christopher Nevala-Plagemann1, Ignacio Garrido-Laguna2

  • 1Division of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Nature Reviews. Clinical Oncology
|April 25, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.9K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K

Related Experiment Videos

Last Updated: Jun 27, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.6K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.9K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

Articles linked to this work by shared authors, journal, and citation graph.

Intravenous hyaluronidase-expressing oncolytic adenovirus with chemotherapy in metastatic pancreatic cancer: a randomized phase 2b trial.

Nature medicine·2026

Daraxonrasib for Previously Treated RAS-Mutant Non-Small-Cell Lung Cancer.

The New England journal of medicine·2026

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

Nature medicine·2026

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.

The New England journal of medicine·2026

Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma.

Cancer research·2026

A modular framework for antibody-drug conjugate biomarkers.

Nature reviews. Clinical oncology·2026

Right-sizing treatment for HER2-positive breast cancer: evolving algorithms across the disease continuum.

Nature reviews. Clinical oncology·2026

Exercise therapy in cancer prevention and treatment.

Nature reviews. Clinical oncology·2026

Exploring the immunological effects of antibody-drug conjugates.

Nature reviews. Clinical oncology·2026

Optimizing the delivery of radiotherapy with artificial intelligence.

Nature reviews. Clinical oncology·2026

Understanding and targeting the tumour matrisome.

Nature reviews. Clinical oncology·2026

Comparative accuracy of imaging modalities for differentiating malignant small testicular masses.

BJU international·2026

Long-Term Outcomes of IDH2-Mutant Sinonasal Carcinomas Compared With IDH2-Wild Type Sinonasal Undifferentiated Carcinoma.

Head & neck·2026

The Effect of Clinicopathological Features and Postoperative Management on Prognosis in Male Breast Cancer.

The breast journal·2026

Population-Based Cohort Study: Colorectal Cancer Risk Stratification in Symptomatic Patients Using the Faecal Immunochemical Test, Blood Results and Patient Characteristics in Wales.

Alimentary pharmacology & therapeutics·2026

Comprehensive Pan-Cancer Analysis Identifies LINC00942 as a Multifunctional lncRNA Involved in Tumor Progression, Immune Regulation, and Chemoresistance.

Asia-Pacific journal of clinical oncology·2026

Proteomic profiling identifies candidate biomarkers for small intestinal neuroendocrine tumours G1 and G2.

Journal of neuroendocrinology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us